183 related articles for article (PubMed ID: 36046479)
1. Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
Seidel MG; Kashofer K; Moser T; Thueringer A; Liegl-Atzwanger B; Leithner A; Szkandera J; Benesch M; El-Heliebi A; Heitzer E
Front Pediatr; 2022; 10():926405. PubMed ID: 36046479
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
[TBL] [Abstract][Full Text] [Related]
3. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from
Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559
[TBL] [Abstract][Full Text] [Related]
4. Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Anderson CJ; Yang H; Parsons J; Ahrens WA; Jagosky MH; Hsu JH; Patt JC; Kneisl JS; Steuerwald NM
Clin Orthop Relat Res; 2024 Jun; ():. PubMed ID: 38905450
[TBL] [Abstract][Full Text] [Related]
5. Circulating Plasma Tumor DNA Is Superior to Plasma Tumor RNA Detection in Ewing Sarcoma Patients: ptDNA and ptRNA in Ewing Sarcoma.
Bodlak A; Chang K; Channel J; Treece AL; Donaldson N; Cost CR; Garrington TP; Greffe B; Luna-Fineman S; Sopfe J; Loeb DM; Hayashi M
J Mol Diagn; 2021 Jul; 23(7):872-881. PubMed ID: 33887462
[TBL] [Abstract][Full Text] [Related]
6. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma.
Krumbholz M; Eiblwieser J; Ranft A; Zierk J; Schmidkonz C; Stütz AM; Peneder P; Tomazou EM; Agaimy A; Bäuerle T; Hartmann W; Dirksen U; Metzler M
Clin Cancer Res; 2021 Nov; 27(21):5922-5930. PubMed ID: 34426444
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
Subhash VV; Huang L; Kamili A; Wong M; Chen D; Venn NC; Atkinson C; Mayoh C; Venkat P; Tyrrell V; Marshall GM; Cowley MJ; Ekert PG; Norris MD; Haber M; Henderson MJ; Sutton R; Fletcher JI; Trahair TN
Br J Cancer; 2022 Feb; 126(3):482-491. PubMed ID: 34471258
[TBL] [Abstract][Full Text] [Related]
9. Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma.
Krumbholz M; Hellberg J; Steif B; Bäuerle T; Gillmann C; Fritscher T; Agaimy A; Frey B; Juengert J; Wardelmann E; Hartmann W; Juergens H; Dirksen U; Metzler M
Clin Cancer Res; 2016 Sep; 22(17):4356-65. PubMed ID: 27283964
[TBL] [Abstract][Full Text] [Related]
10. Routine EWS Fusion Analysis in the Oncology Clinic to Identify Cancer-Specific Peptide Sequence Patterns That Span Breakpoints in Ewing Sarcoma and DSRCT.
Anderson PM; Tu ZJ; Kilpatrick SE; Trucco M; Hanna R; Chan T
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900411
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.
Shulman DS; Klega K; Imamovic-Tuco A; Clapp A; Nag A; Thorner AR; Van Allen E; Ha G; Lessnick SL; Gorlick R; Janeway KA; Leavey PJ; Mascarenhas L; London WB; Vo KT; Stegmaier K; Hall D; Krailo MD; Barkauskas DA; DuBois SG; Crompton BD
Br J Cancer; 2018 Aug; 119(5):615-621. PubMed ID: 30131550
[TBL] [Abstract][Full Text] [Related]
12. Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors.
van Zogchel LMJ; Lak NSM; Gelineau NU; Sergeeva I; Stelloo E; Swennenhuis J; Feitsma H; van Min M; Splinter E; Bleijs M; Groot Koerkamp M; Breunis W; Meister MT; Kholossy WH; Holstege FCP; Molenaar JJ; de Leng WWJ; Stutterheim J; van der Schoot CE; Tytgat GAM
Front Oncol; 2023; 13():1124737. PubMed ID: 37152023
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives.
Peng Y; Mei W; Ma K; Zeng C
Front Oncol; 2021; 11():763790. PubMed ID: 34868984
[TBL] [Abstract][Full Text] [Related]
14. Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia: A Proof of Concept Study.
Arthur C; Rezayee F; Mogensen N; Saft L; Rosenquist R; Nordenskjöld M; Harila-Saari A; Tham E; Barbany G
Front Oncol; 2022; 12():899325. PubMed ID: 35865473
[TBL] [Abstract][Full Text] [Related]
15. Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management.
Wehrle J; Philipp U; Jolic M; Follo M; Hussung S; Waldeck S; Deuter M; Rassner M; Braune J; Rawluk J; Greil C; Waller CF; Becker H; Duque-Afonso J; Illert AL; Fritsch RM; Meiss F; Duyster J; von Bubnoff N; Scherer F
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32748806
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma.
Nordentoft I; Lindskrog SV; Birkenkamp-Demtröder K; Gonzalez S; Kuzman M; Levatic J; Glavas D; Ptashkin R; Smadbeck J; Afterman D; Lauterman T; Cohen Y; Donenhirsh Z; Tavassoly I; Alon U; Frydendahl A; Rasmussen MH; Andersen CL; Lamy P; Knudsen M; Polak P; Zviran A; Oklander B; Agerbæk M; Jensen JB; Dyrskjøt L
Eur Urol; 2024 May; ():. PubMed ID: 38811314
[TBL] [Abstract][Full Text] [Related]
17. Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.
Benesova L; Ptackova R; Halkova T; Semyakina A; Svaton M; Fiala O; Pesek M; Minarik M
Pathol Oncol Res; 2022; 28():1610308. PubMed ID: 35837614
[No Abstract] [Full Text] [Related]
18. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
19. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
20. Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas.
Tsoi KM; Gokgoz N; Darville-O'Quinn P; Prochazka P; Malekoltojari A; Griffin AM; Ferguson PC; Wunder JS; Andrulis IL
Bone Joint Res; 2021 Sep; 10(9):602-610. PubMed ID: 34558310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
